Programme
Sunday, September 20, 2026
-
08:00–15:00
Satellite Program (Pre-congress activities)
-
08:00–13:00
Post-Graduate Course - Clinical Program
-
08:00–13:00
Post-Graduate Course - Fundamental and translational science
-
08:00–13:00
Pediatric Transplantation
-
08:00–15:00
Transplant Infectious Diseases (TID)
Organized by
In collaboration with
-
08:00–13:00
Global nursing and allied health leadership in organ donation and transplantation
Organized by: TTS Allied Health Committee - In Collaboration with
-
08:45–13:00
Women in Transplantation
Organized by:
-
09:00–12:30
TSANZ Research Accelerator Showcase
Organized by:
-
13:30–14:30
From principles to practice: Advancing diversity, equity, and inclusion in transplantation
Supported by:
in partnership with:
Chairs: Nazia Selzner (CA); Cynthia Tsien (CA)
2SLGBTQI-Inclusive care in organ donation and transplantationCarmen Hrymak (CA)Innovations to improve equity and access in pediatric kidney transplantationAviva Goldberg (CA)Mindfulness and meaning in transplant medicine: Supporting the workforceChaya Shwaartz (CA) -
15:00–18:30
Opening Ceremony & Plenary Session
-
15:00–16:30
Opening Ceremony
-
16:45–18:30
Plenary Session 1 (with Starzl and Kanoria Awards)
Artificial intelligence in medicineKarin Verspoor (AU)
-
18:30–20:00
Welcome Reception
Monday, September 21, 2026
-
08:00–09:15
Morning Abstract and Concurrent Sessions
-
08:00–09:00
Local/Regional insights for global organ donation advancement
Chairs: Gabriel E. Gondolesi (US); Chloë Ballesté Delpierre (ES)
- 08:00–09:00 Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
-
08:00–09:00
Vasculopathy: A tale of three organs
What should we continue to learn from renal allograft pathologyMariam Alexander (US)
-
08:00–08:45
Takeda Corporate Breakfast Symposium on Illuminated constellations: How diverse experiences guide practical CMV
Organized by
-
09:15–10:30
Plenary and Concurrent Sessions
-
09:15–10:30
Plenary Session 2 on Making Xenotransplantation Work for Humanity!
Chairs: Peter Cowan (AU); Macey L. Levan (US)
Clinical xenotransplantation: Experience to dateTatsuo Kawai (US)Xenozoonosis, no worries!Anoma Nellore (US)Let’s start with hearts (or lungs?)!Richard N. Pierson (US)Let’s start with islets!Wayne J. Hawthorne (AU)The ethics of new technology in xenotransplantationLuz Padilla (US)Panel DiscussionDiscussion Period (AU) -
09:15–10:30
Beyond survival: Addressing mental health in transplantation
Why survival alone is not sufficient for transplant successsMariel Nöhre (DE)Psychological distress across the transplant journeyIris Fontanilla (NZ)Practical strategies for integrating mental health in transplant careMing Hwei Yek (US)Panel DiscussionDiscussion Period (AU)
-
09:15–10:30
Dedicated donor care units: Centralized donor transfer and outcome optimization
Chairs: David Thomson (ZA); Dan Harvey (GB)
25 years of innovation: The St. Louis donor care unitGary F. Marklin (US)The US donor care unit landscapeJennifer Prinz (US)Panel DiscussionDiscussion Period (AU) -
10:30–11:00
Coffee Break / Exhibits and Poster Viewing
-
10:30–11:00
Coffee Break
-
11:00–12:00
Abstract and Concurrent Sessions
-
11:00–12:00
DCD: Controlled and uncontrolled—Where are we going?
Chair: Kenneth J. Woodside (US)
Role of ICU physiciansSara Alcantara Carmona (ES)Question PeriodDiscussion Period (AU) -
11:00–12:00
The -omic era in allograft pathology
Does metabolic phenotype in the kidney affect transplant outcome?Ana Konvalinka (CA)Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical modelsAlexandra Sharland (AU)
-
11:00–12:00
Transplantation journals: Updates and opportunities
Chairs: Stefan Tullius (US); Fadi Issa (GB)
Structure, achievements, goals – Getting your work published, recognized and highlightedStefan Tullius (US)Transplant-Direct: The online campaign journal with an own agendaEdward Geissler (DE)AI and publishing: When, how and what is legit?Germaine Wong (AU) -
12:00–13:30
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:15–13:15
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Organized by
-
12:30–13:15
Lunch and Learn Roundtable
CMV GuidelineAtul Humar (CA)Medical Assist in Dying (MAID) and benefit to organ donationMatthew Weiss (CA)Survival outcome impact related to distance from transplant centerSusumu Eguchi (JP)Pediatric cardiovascular health and patient survivalAnette Melk (DE)Induction and mechanisms of transplant toleranceXunrong Luo (US)Alternative islet transplant sitesToby Coates (AU)Transplant policy, development and education to improve access and quality of kidney transplantation across Latin AmericaPaola Karina Garcia Padilla (CO)Roundtable MentorGabriel E. Gondolesi (US)Roundtable MentorHelen Opdam (AU)Roundtable MentorDorry Segev (US)Roundtable MentorSiah Kim (AU)Roundtable MentorFadi Issa (GB)Immunological monitoring of the pancreas graftPablo Uva (AR)
-
13:30–15:00
SOTA, Thematic and Concurrent Sessions
-
13:30–15:00
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Chair: Anne Floden (SE)
Driving excellence in transplant care: The role, vision and impact of the tts allied health committeeEstephan Arredondo (ES)Extending organ viability: The role of allied health in machine perfusion programsJoaquim Albiol (ES)Strategies to improve adherence after solid organ transplantationMariel Nöhre (DE)Panel discussionBronwyn Levvey (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Chair: Ahmer Mohammad Hameed (AU)
Pancreas transplantation in type 2 diabetes mellitusPeter G. Stock (US)Diagnosis and treatment of pancreas rejectionPablo Uva (AR)Islets and stem cells in diabetes therapy: Current statusEelco de Koning (NL) -
13:30–15:00
Minimal Invasive Transplantation
Minimally invasive thoracic organ transplantationAlbert Jauregui (ES)Minimally invasive abdominal organ transplantationKwang Woong Lee (KR)Education and training strategies to safely disseminate robotic organ transplantationJinna Yao (AU)Future technological development in robotic organ transplantationDieter Broering (SA)
-
13:30–15:00
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
mNGS and rapid diagnostics: The next frontier in donor screening?Maricar Malinis (US)HIV-positive organ donation: Evolving guidelines and global perspectivesCameron Wolfe (US)MDRO: Cross-disciplinary approaches to donor-derived infection risk assessmentPriscilla Rupali (IN)Donors in the tropics and LMICs: What to consider?Siriorn Watcharananan (TH)
-
13:30–15:00
Using Technology to optimize outcomes of Liver Transplantation
Chair: Shantanu Bhattacharya (AU)
Ischemia-free organ transplantationGuo Zhiyong (CN)The future for artificial Intelligence in liver transplantDorry Segev (US) -
13:30–15:00
Precision Immune Engineering in Kidney Transplantation
Next-generation co-stimulation blockadeCheng Yang (CN)Regulatory T-cell therapy 2.0: CAR-TregsMegan Levings (CA)Emerging pharmacotherapies for desensitization in HLA incompatible kidney transplantationMarta Crespo Barrio (ES)
-
13:30–15:00
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Global uterus transplantation activities and outcomes: the ISUTx registryMats Brännström (SE)Robotic surgery in uterus transplantationJean-Marc Ayoubi (FR)Setting up a uterus transplantation programRebecca Deans (AU)Updates on treatment and donor/recipient selectionPaige Porrett (US)
-
13:30–15:00
Harnessing the Power of Genetics in Pediatric Transplantation
Overview of genomic sequencing techniquesKatherine E. Twombley (US)When and why to consider genetic testing pre-transplantHugh McCarthy (AU)Bioethics in transplant gene testingAnne Priesz (AU)
-
13:30–15:00
How to combat transplant tourism
Chair: Thomas F. Müller (CH)
Patients traveling overseas for transplants - Practical experiencesAnantharaman Vathsala (SG)Challenges in registering unethical travel for transplant activitiesDominique Martin (AU)The living donor liver registryDimitri A. Raptis (SA)Tools to detect and report suspicious cases of traffickingMaria Amalia Matamoros (CR)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Senotherapy in transplantation
Global and local consequences of ‘environmental sciences’ on organ ageStefan Tullius (US)Cell-type and sex specific aspects of senescenceAnette Melk (DE)Aged immune systems drives organ agingMatthew Yousefzadeh (US)
-
13:30–15:00
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Equity and access in fragile health systems: A south asian perspectiveDivya Singh Shah (NP)
-
13:30–15:00
The mentorship mosaic: Fostering growth in transplant training and practice
Chairs: Sarah Tsou (US); Natasha Rogers (AU)
Panel discussantFriederike Martin (DE)Panel discussantGomathy Narasimhan (IN)Panel discussantKhushboo Saxena (IN) -
13:30–15:00
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Chair: Sang Joseph Kim (CA)
Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared frameworkSang Joseph Kim (CA)Creating a transplant registry: Defining purpose, scope, and sustainable infrastructureGermaine Wong (AU)Establishing trust: Governance, ethics, and legal architecture of transplant registriesAxel Rahmel (DE)From aspirational standards to practical assessment: Introducing the transplant registry maturity modelYee Lu (US)Panel DiscussionDiscussion Period (AU)PanelistNicole Jane Scholes-Robertson (AU) -
15:00–15:30
Coffee Break / Exhibits and Poster Viewing
-
15:00–15:30
Coffee Break
-
15:30–16:30
Afternoon Abstract and Concurrent Sessions
-
15:30–17:00
From patient to planet: The global essential standards as a framework for transformative change in transplantation
Chair: John J. Fung (US)
The human face of standardsJohn J. Fung (US)Dignity for all: The human covenant: How the global essential standards protect every individual in the transplant encounterEfstratios (Stratos) Chatzixiros (CH)The institutional blueprint: How the global essential standards create a transplant ecosystem that is equitable, safe, and self-sustainingMedhat Askar (QA)Stakeholders perspective from China: Translating standards into value for every actor in the ecosystemHaibo Wang (CN)Stakeholders perspective from Australia: Translating standards into value for every actor in the ecosystemHelen Opdam (AU)Connecting the circles: Panel discussionsDiscussion Period (AU)PanelistKaren Rockwell (GB) -
15:30–16:30
Advancing ABO histocompatibility: Needs and solutions
ABO antigens and antibodies: Updating old dogmasAnne Halpin (CA)ABO incompatible kidney transplantation, strategies and successesMarta Crespo Barrio (ES)
-
15:30–16:30
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Chairs: Pablo Sanchez (US); Raj Ramanan (US)
The role of NRP and machine perfusion in cardiothoracic transplantationSandra Lindstedt Ingemansson (SE)Complex decisions: Ethical dilemmas of ECMO, DCD and NRP donorsEmily Granger (AU) -
16:45–18:00
Workshop Sessions / Industry Symposium / Poster Sessions
-
16:45–18:00
Sex, cancer, and the graft: What women need most from transplant care
Do women do better or worse – What the data say across cancer and transplant?Brenda Maria Rosales (AU)Post transplant care: Patient perspectivesNicole Jane Scholes-Robertson (AU)
-
16:45–18:00
Transplant without borders: Collaborative solutions for global kidney care
The global interdependence of health and the burden of kidney disease as a pressing public health priorityBenita Padilla (PH)Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortalityShyam Bihari Bansal (IN)Overcoming the challenges in achieving equity in global access to kidney transplantationBeatriz Domínguez-Gil (ES)
-
16:45–18:00
Optimizing cardiometabolic health across the lifespan following transplantation
-
16:45–18:00
Poster Session 1
-
17:00–18:00
Industry Symposium
-
18:00–20:00
Networking Events
-
18:00–19:00
WIT Networking Event
-
19:00–21:00
Early Career Networking
Tuesday, September 22, 2026
-
08:00–09:00
Morning Abstract and Concurrent Sessions
-
08:00–09:00
Pediatric treatments on the Horizon
Partial heart transplant in childrenTaufiek Konrad Rajab (US)Regulatory cell therapy for solid organ transplantationFadi Issa (GB)
-
08:00–09:00
Delivering value in liver transplantation: Innovation, resources, and the future of care
Defining value in liver transplantation: Focusing on what mattersMadhukar Patel (US)
-
08:00–08:45
Bridge2Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs
Organized by
-
09:15–10:30
TTS Plenary's Plenary
- 09:15–10:30 TTS President's Plenary
-
10:30–11:00
Coffee Break / Exhibits and Poster Viewing
-
10:30–11:00
Coffee Break
-
11:00–12:00
Abstract and Concurrent Sessions
-
11:00–12:00
Expanding donor strategies and improving outcomes in pediatric transplantation
-
11:00–12:00
Optimizing and utilizing old organ donors
Setting the stage: Older organs - clinical need, ethical and economic considerationsKrista Lentine (US)Objective quality criteria of old organsVarvara Kirchner (US)Old organs and ex vivo treatmentJasper Iske (DE)
-
11:00–12:00
Global Transplantation: The GODT Report Analyzes Activities Around the World
Chairs: John J. Fung (US); Nadey Hakim (GB)
Global observatory on donation and transplantation (GODT)Beatriz Domínguez-Gil (ES)Global donation and transplantation activities. An assessment of 2024 GODT dataFriederike Martin (DE) -
11:00–12:00
The journey to clinical xenotransplantation
Development of the gene edited pigs to get us to the clinicPeter Cowan (AU)The road to regulatory approval for clinical transplantationMuhammad Mohiuddin (US)
-
12:00–13:30
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:15–13:15
Astellas Corporate Lunch Symposium on Strengthening the foundation: From tacrolimus consistency to durable graft outcomes
Organized by
-
12:30–13:15
Lunch and Learn Roundtable
Organ preservation, rejuvenation, and perfusion techniquesStefan Tullius (US)Living donor kidney transplantation & paired exchangeVivek Kute (IN)BK GuidelinesCamille N. Kotton (US)"Organ Donation: From Death to Life". How to improve education about organ donationDavid Thomson (ZA)Grant ManagementShaifali Sandal (CA)Transplant immunology & kidney injuryNatasha Rogers (AU)Nursing Leadership in Transplant and Donation SystemsAnne Floden (SE)Roundtable MentorNicole Isbel (AU)Roundtable MentorPeter G. Stock (US)Roundtable MentorWenshi Jiang (CN)Roundtable MentorMarcelo Cantarovich (CA)AMR in kidney transplant recipientsWilliam Mulley (AU)What strategies can effectively prevent unethical practices in donation and transplantation?Maria Amalia Matamoros (CR)DCD thoracic transplantGregory I. Snell (AU)
-
13:30–15:00
SOTA, Thematic and Concurrent Sessions
-
13:30–15:00
Deceased Donation Research: Findings and Future Directions
Chair: Dominique Martin (AU)
Donor intervention studies – ethical and practical challengesDan Harvey (GB)Deceased donor physiological management researchGary F. Marklin (US)Thoracic ex-situ machine perfusion researchSarah Scheuer (AU)Biobanks for researchClaire Gordon (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Targeting immune cell metabolism to control alloimmunity
How T cell metabolism regulates function and survivalCarl Atkinson (US)Treg metabolism and the impact of metabolites on their function and disease progressionLing Lu (CN)T cell landscapes following hematopoietic stem cell transplantationAntiopi Varelias (AU)
-
13:30–15:00
Artificial intelligence (AI) in Transplant Education
From concept to classroom: How to start using AI in transplant education?Susu Zughaier (QA)Mixed reality technology in organ transplantationAlfred Kow (SG)Panel DiscussionDiscussion Period (AU)
-
13:30–15:00
Transplanting Against the Antibody Odds
Chair: Ankit Sharma (AU)
Overview of new HLA tools for measuring antibodies and rapid high resolution sequencingSandra Tafulo (PT)Crossing DSA in lung transplant: Is necessity the mother of invention?Kieran Halloran (CA)Immune memory responses: Unmasking the hidden antibody potentialGonca E. Karahan (NL)Organ allocation strategies for HLA compatibilityPhilip Andrew Clayton (AU) -
13:30–15:00
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Chair: Animesh Singla (AU)
Novel outcome metrics in surgeryPierre-Alain Clavien (CH)Driving quality improvement through global surgical registriesDimitri A. Raptis (SA)Ensuring diversity in the transplant surgery workforceKendra Conzen (US) -
13:30–15:00
Biology and beyond: Multiple dimensions of transplantation
Chairs: Yolanda Becker (US); Philip O'Connell (AU)
Addressing gender disparity in access to pediatric kidney transplantation in IndiaKinnari Vala (IN)Social and cultural conflicts in uterine transplantationLimor Meoded Danon (IL)Impact of sex on cardiovascular outcomes after pediatric kidney transplantationRizky Indrameikha Sugianto (DE)Intersection of sex/gender, and cancer after transplantationBrenda Maria Rosales (AU) -
13:30–15:00
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Latest evidence on GLP-1s in transplantationBabak Orandi (US)Managing obesity without GLP-1s: Alternative strategiesAmanda Velazquez (US)Bariatric surgery in transplantation: Opportunities and challengesShashank R. Joshi (IN)Facilitating weight loss in individuals with frailty and sarcopeniaAstrid Ruiz-Margáin (MX)
-
13:30–15:00
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Pluripotent stem cells: Where are we in building new lungs?Rhiannon Werder (AU)
-
13:30–15:00
Transplant Oncology: Peering Over the Horizon
Chair: Kwang Woong Lee (KR)
Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?Julie Heimbach (US)Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?Takashi Ito (JP)Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possibleSudha Kodali (US)Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?Mohamed Rela (IN)Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?Seisuke Sakamoto (JP) -
13:30–15:00
Honouring voices, changing systems: Indigenous leadership in transplant equity
Building an indigenous lived experience database in organ donation and transplantationCaroline Tait (CA)Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New ZealandCurtis Walker (NZ)Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you MobStephen McDonald (AU)Panel Discussion and Q&ADiscussion Period (AU)
-
13:30–15:00
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Capacity building in low-resource settingsMedhat Askar (QA)
-
13:30–15:00
Emerging infectious diseases in transplant ID
Climate change and the changing epidemiology of transplant infectionsWanessa T. Clemente (BR)New outbreaks of old diseases: Measles and other re-emerging threats in transplantationCameron Wolfe (US)Disease X and vaccineDeepali Kumar (CA)
-
13:30–15:00
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Clinical perspective: Encouraging safe physical activity after transplantGeoffrey McCaughan (AU)Panel discussion: Supporting all patients to moveDiscussion Period (AU)
-
13:30–15:05
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
Chairs: Ravi Mohanka (IN); Swarnalatha Guditi (IN); Divyesh Engineer (IN); Amit Pasari (IN); Abi Abraham (IN); Amol Bhawane (IN); Sreebhushan Raju (IN); Manish Balwani (IN); Feroz Aziz (IN)
Government reforms to increase access to organ transplantation: Policy innovations and outcomesAnil Kumar (IN)Optimizing transplant outcomes through cost-effective immunological evaluation in LMICsManoj Gumber (IN) -
15:00–15:30
Coffee Break / Exhibits and Poster Viewing
-
15:00–15:30
Coffee Break
-
15:30–16:30
TSANZ President Session / Afternoon Abstract and Concurrent Sessions
-
15:30–18:00
TSANZ President's Prize Awards
-
15:30–16:30
Solving immune problems for the life of the allograft
Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyondMariam Alexander (US)Direct and indirect allorecognition – more alike than we thought?Gavin Pettigrew (GB)
-
15:30–16:30
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
in collaboration with:
The pregnancy after renal transplantation OUTcomes registry (PARTOUT) in the Netherlands with granular dataMargriet de Jong (NL)Assessing risk and overcoming barriers in pregnancy after kidney transplantationShilpanjali Jesudason (AU) -
15:35–18:10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
Chairs: Shruti Tapiawala (IN); Gireesh MS (IN); Mohan Patel (IN); Raj Kanwar Yadav (IN); Dhananjai Agarwal (IN); Dhananjaya KL (IN); Pranjal Kashiv (IN); Ashish Sharma (IN); Narayan Prasad (IN); Arpita Ray Chaudhury (IN); Vrushali Deshpande (IN); Vikas Jain (IN); Sourabh Sharma (IN); Pankaj Shah (IN)
Making ABO-incompatible transplantation affordable for low- and middle-income countries: Scalable cost-reduction strategiesDeepak S. Ray (IN)HLA desensitization in transplantation in LMIC: Balancing access, cost, and clinical outcomesUmapati Hegde (IN)Integrating cell-free DNA surveillance into cost-effective organ transplantation pathways in LMIC settingsPratik Das (IN)Gender disparity in organ transplantation: Insights and lessons from LMICKhushboo Saxena (IN)Pioneering surgical techniques in transplantation: The global south contribution to global practicePranjal Modi (IN)ISOT position statements for increasing access to transplantationJigar Shrimali (IN) -
16:45–18:00
Workshop Sessions / Industry Symposium / Poster Sessions
-
16:45–18:00
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Immunologic bridgeRajdeep Das (US)One pathogen, two populationsMonica Slavin (AU)Beyond the graftTeun van Gelder (NL)Panel discussion on global perspectives on integration and innovationDiscussion Period (AU)
-
16:45–18:00
Approaching and navigating difficult conversations with transplant patients
Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplantRhiannon Reed (US)Palliative care post-transplant: Throughout patient journey and symptom managementKathryn Ducharlet (AU)Navigating through organ failure to transplant: Liver transplantSuk Kyun Hong (KR)Navigating conversations on cardiac mechanical support therapy to heart transplantShunichi Nakagawa (US)
-
16:45–18:00
Poster Session 2
-
17:00–18:00
Industry Symposium
-
18:00–20:00
Networking Events
-
18:00–19:00
TSANZ Networking Event
-
18:00–19:00
Mentee-Menor Networking Events
-
19:00–22:00
Congress Networking Event (ICC)
Wednesday, September 23, 2026
-
08:00–09:00
Morning Abstract and Concurrent Sessions
- 08:00–09:00 Metabolic dysfunction and liver transplantation
-
08:00–09:00
Key components of an ideal high volume transplant program setup: A global surgical perspective
The European perspectiveJiri Fronek (CZ)The Oceania perspectiveHenry Pleass (AU)Panel discussionDiscussion Period (AU)
-
08:00–08:45
Biogen Corporate Breakfast Symposium on Advancements in Antibody-Mediated Rejection and Microvascular Inflammation of Kidney Allograft
Organized by
-
08:00–09:30
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
Chairs: Wanessa T. Clemente (BR); Jeremy Chapman (AU)
Pearls from the BK guidelinesNassim Kamar (FR)Pearls from the CMV guidelinesCamille N. Kotton (US)Beyond the guidelines- new developments and future directions: BKGermaine Wong (AU)Panel discussion: challenging BK case, challenging CMV caseDiscussion Period (AU) -
09:15–10:15
Abstract and Concurrent Sessions
-
09:15–10:15
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
Importance of HLA beyond the A/B/DRAnat Tambur (US)Beyond HLA: Expanding the immunologic landscapeToby Coates (AU)Precision risk stratificationWai Lim (AU)
-
09:15–10:15
Transplantation beyond traditional publications
Chairs: Stefan Tullius (US); Macey L. Levan (US)
Social media: Are we reaching our audience and readership worldwideJasper Iske (DE)Editorial fellowships: A great opportunity to be involvedMelanie Wyld (AU)Topic highlights – Article seriesCamille N. Kotton (US)Panel discussionDiscussion Period (AU)PanelistKhushboo Saxena (IN) -
10:15–10:45
Coffee Break / Last chance to visit Exhibit Area
-
10:15–10:45
Coffee Break
-
10:45–12:30
Plenary and Concurrent Sessions / TTS Business Meeting
-
10:45–12:00
Plenary Session 3
Towards transplantable organs: Vascularized kidney organoids for renal regenerationTon J. Rabelink (NL)
-
10:45–12:00
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Chairs: Pablo Uva (AR); Toby Coates (AU)
Current status of pancreas transplantation: Activity and outcomes around the worldAngelika C. Gruessner (US)Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomesJoana Ferrer (ES)Future of pancreas transplantation in the landscape of emerging therapiesRaja Kandaswamy (US) -
12:00–12:30
TTS Business Meeting
-
12:30–13:45
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:45–13:45
Industry Symposium
-
12:45–13:30
Lunch and Learn Roundtable
Combined liver–kidney transplantationGomathy Narasimhan (IN)Designing and strengthening organ donation systemsMarti Manyalich Vidal (ES)Genetic factors influencing transplant outcomesStephen Alexander (AU)Clinical Trials in Kidney TransplantationSteve J. Chadban (AU)From HLA typing to epitope matchingLucy Sullivan (AU)Encouraging physical activity in transplant recipients with limited endurance or physical limitationsLiz Schick (CH)Roundtable MentorRoslyn B. Mannon (US)Roundtable MentorGermaine Wong (AU)Roundtable MentorKate Wyburn (AU)Roundtable MentorMedhat Askar (QA)Roundtable MentorMacey L. Levan (US)Roundtable MentorHenry Pleass (AU)TBD related to Uterus Transplant (ethics or donor/recipient selection or pregnancy challenge, etc)Mats Brännström (SE)Multi-Organ transplantation in childrenTomoaki Kato (US)
-
13:45–15:15
SOTA, Thematic and Concurrent Sessions
-
13:45–15:15
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Chairs: Giuseppe Orlando (US); Ekaterine Berishvili-Berney (CH)
The bioartificial kidney: Lessons learned and the road aheadWilliam Fissell (CA)Organoids, organs-on-a-chip, and the path to organ manufacturingSean Vincent Murphy (US)Artificial heart: A life-saving bridge to transplantFrancisco Arabia (US) -
13:45–15:15
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Chair: Jen Li (AU)
Is there still a role for anti IL-6R in ABMR treatment?Roslyn B. Mannon (US)Is anti-CD38 the most promising agent for ABMR?Katharina Mayer (AT)What does monitoring AUC add compared to C-trough only?Teun van Gelder (NL)Model Informed precision dosingAnders Asberg (NO) -
13:45–15:15
Clinical Xenotransplantation has Arrived!
Understanding optimal genetic modificationPeter Cowan (AU)Experience and immunosuppression for clinical xenotransplantationRaphael Meier (US)Molecular analysis in clinical xenotransplantationCarmen Lefaucheur (FR)
-
13:45–15:15
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Chairs: Miranda Paraskeva (AU); Pablo Sanchez (US)
Debate 1: Pro normothermic regional perfusionAshish S. Shah (US)Debate 1: Pro ex vivo machine perfusionPeter MacDonald (AU)Debate 2: Pro ex vivo perfusionSandra Lindstedt Ingemansson (SE)Debate 2: Pro immediate transplantGregory I. Snell (AU)Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recoveryIrene Bello Rodriguez (ES)Panel DiscussionDiscussion Period (AU) -
13:45–15:15
State of VCA- Present and Future
Chairs: Patrik Lassus (FI); Hatem Amer (US)
Overview of VCA transplantsHatem Amer (US)VCA becoming part of universal health careDavid Leonard (GB)Is VCA reconstructive surgery or transplantationLinda C. Cendales (US)Challenges and opportunities for VCA in the global southSubramania Iyer (IN)Standardizing outcomes in VCA: Are we ready for a SONG or for COVERAllison Jaure (AU) -
13:45–15:15
Evolving Ethics and Emerging Trends in Transplantation
Chairs: David Thomson (ZA); Aviva Goldberg (CA)
Rating ourselves on the ethics of NRP - How are we doing?Anji Wall (US)Social media use in transplantationShaifali Sandal (CA)Ethical tissue sourcing for organoids: Why and HowKatrina Bramstedt (CH)Pediatric prioritizationThozama Siyotula (ZA)Retransplantation after nonadherence (adult & children)Aaron Wightman (US) -
13:45–15:15
Evolving strategies in intestinal and multivisceral transplantation
Chairs: Helen Evans (NZ); Rajith Amaratunga (AU)
Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonistYaron Avitzur (CA)Novel immunosuppression in intestine transplantationJennifer Garcia (US)Pros and cons of protocol biopsy and stomaJonathan Hind (AU) -
13:45–15:15
Diversity, Equity, and Inclusion in Gender and Transplantation
Regional and gender disparities in abstracts presented at international transplant congressMaggie Kam Man Ma (HK)Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantationElmi Muller (ZA)Redefining equity: Women, access, and outcomes in liver transplantationGomathy Narasimhan (IN)
-
13:45–15:15
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Shared framework for living donor evaluation: medical, psychosocial, and ethical coreKrista Lentine (US)Surgical challenges and functional outcomes in living kidney donationMireia Musquera (ES)Surgical challenges and functional outcomes in living liver donationDongJin Joo (KR)Predictive models and global registry insights to enhance donor safetyAllan Massie (US)
-
13:45–15:15
Innovations in skin cancer in transplantation
Chairs: Angela Webster (AU); Brenda Maria Rosales (AU)
Skin cancer risk prediction and communicationAnne Cust (AU)Complex surgical oncologyAlexander Varey (AU)Novel developments in keratinocyte cancer treatments in AustraliaKiarash Khosrotehrani (AU)Panel DiscussionDiscussion Period (AU) -
13:45–15:15
Pediatric cholestatic liver disease around the world
Chairs: Gabriel E. Gondolesi (US); Manuel Rodriguez-Davalos (US)
Biliary atresia - whats happening in Latin America. Access to KPE and transplantationMonserrat Arreola Gutierrez (MX)Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapyMohamed Rela (IN)Primary sclerosing cholangiotis in children and adolescentMichael Stormon (AU) -
13:45–15:15
Organ donation following MAID (VAD/euthanasia)
Chair: Helen Opdam (AU)
Panelist representing CanadaMatthew Weiss (CA)Panelist representing AustraliaWade Stedman (AU) -
15:20–16:30
Closing Plenary
-
15:20–16:30
Closing Plenary
Gene and cell therapy in transplantationMaria Grazia Roncarolo (US)